baber/WOPTO huggingface dataset:
Patent NZ-538180-A (NZ)
Title: Drinking apparatus, typically in the form of a teat, to prevent spillage, with flow caused by user compressing teat to open valve
Inventor: HAKIM NOURI E
IPC: A61J11/02
Filed: 2003-08-05
Abstract: Disclosed is a "no-spill" drinking product which is stated to provide an extremely secure seal against accidental liquid flow when the user is not drinking therefrom. Various embodiments are disclosed.
Patent NZ-540791-A (NZ)
Title: Novel 2-pyridinecarboxamide derivatives
Inventor: MITSUYA MORIHIRO
IPC: A61K31/4439
Filed: 2004-02-13
Abstract: Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein D is O or S, ring A is an optionally substituted triazolyl, imidazolyl, thiazolyl, or pyridyl group, ring B is an optionally substituted triazolyl, thiadiazolyl, isoxazolyl, pyrazinyl, pyridothiazolyl, or pyridyl group, and where the other substituents are as disclosed in the specification. Also disclosed is the use of the compound to treat diabetes mellitus or obesity.
Patent NZ-548310-A (NZ)
Title: Frequency error estimation and frame synchronization in an OFDM system
Inventor: VIJAYAN RAJIV
IPC: H04L27/26
Filed: 2005-01-07
Abstract: Frequency error estimation and frame synchronization are performed at a receiver in an OFDM system based on a metric that is indicative of detected pilot power. The metric may be defined based on cross-correlation between two received symbols obtained in two OFDM symbol periods. For frequency error estimation, a metric value is computed for each of multiple hypothesized frequency errors. The hypothesized frequency error for the metric value with the largest magnitude is provided as the estimated frequency error. For frame synchronization, a correlation value is obtained for each OFDM symbol period by correlating metric values obtained for NC (e.g., most recent) OFDM symbol periods with NC expected values. The expected values are computed in a manner consistent with the manner in which the metric values are computed. Peak detection is performed on the correlation values obtained for different OFDM symbol periods to determine frame synchronization.
Patent NZ-548816-A (NZ)
Title: Method and kit for the measurement of neutrophil cell activation
Inventor: SERTEYN DIDIER
IPC: G01N33/569
Filed: 2005-02-07
Abstract: Disclosed are methods and kits for measuring the activation status of neutrophil cells, in particular equine neutrophil cells comprising specifically measuring the myeloperoxidase (MPO) content of a sample, said content being correlated with said cell activation status. In particular disclosed is a method comprising: a) immunocapturing MPO present in a biological sample obtained from a mammal via a MPO-specific polyclonal or monoclonal antibody, b) detecting and/or measuring either total (active and inactive) MPO or exclusively active MPO present in said biological sample, and c) relating the MPO levels measured to an activity status of said cells indicative of the presence, absence or condition of a disease or immunological status.
Patent NZ-562501-A (NZ)
Title: A gas regulating valve for a breathing assistance device that allows control of the opening of leakage orfice
Inventor: CHALVIGNAC PHILIPPE
IPC: A61M16/20
Filed: 2005-05-02
Abstract: A breathing assistance device for a patient breathing in successive respiratory cycles and a gas regulating valve (32) for use in such device is disclosed. The device comprises a central unit (30) which includes an internal gas source (S) for feeding a patient (P) with respiratory pressurised gas. The device further includes a gas transmission circuit between the central unit (30) and the patient (P) so as to allow the patient to inspire and expire. The device includes a controlling means (35) for controlling a gas regulating valve (32) via a connection link. The controlling means (35) is associated with a measurement means (34) which a gas flow sensor and a pressure sensor. The controlling means (35) also includes a data processing means, to enable processing of the signals coming from the different measurement means (34). The regulating valve (32) of the device allows control of the opening of a leakage orifice during expiration to control a Positive Expiratory Pressure in the presence and absence of a signal from the controlling means (35).
Patent NZ-562519-A (NZ)
Title: Histone deacetylase (HDAC) inhibitors
Inventor: MOFFAT DAVID FESTUS CHARLES
IPC: A61K31/397
Filed: 2006-05-15
Abstract: Disclosed is a compound of formula (I), wherein B is a divalent radical selected from options as provided in the specification and A is cyclic ring. The remaining substituents are as defined in the specification. The compounds are histone deacetylase inhibitors useful in the treatment of a number of diseases and conditions including proliferative diseases, neurodegenerative diseases and autoimmune diseases.
Patent NZ-581037-A (NZ)
Title: Grain puffing apparatus
Inventor: CHOI KI HONG
IPC: A23L7/196
Filed: 2008-04-10
Abstract: A grain puffing apparatus comprises a motor 10, a screw 20 coupled to the motor 10 which transfers and compresses grain while rotating, a first screw spiral 21 formed on the outer circumferential surface of the screw 20 in a certain direction, a second screw spiral 22 which is formed from the central portion of a first pitch of the first screw spiral 21 on the outer circumferential surface of the screw 20 and in the same direction as the first screw spiral 21, a thread hitch 23 that is formed on the other end of the screw 20 and connects the threads forming the first screw spiral 21 and the second screw spiral 22, a screw groove 24 formed on the other end of the screw 20 and along the circumferential direction of the screw 20, a cylinder 30 that surrounds the outer circumferential surface of the screw 20 and compresses and heats the grain when the screw 20 pushes the grain against it thus changing the grain into a gel state, first and second cylinder spirals 31, 32 which are formed on the inner circumferential surface of the cylinder 30 in correspondence to the first screw spiral 21 and the second screw spiral 22 respectively, a grain inlet 33 formed at the motor end of the cylinder 20, and a puffing unit 40 which puffs the gelled grains produced by the screw 20 and the cylinder 30. The puffing unit 40 comprises a main body 41 with an open side and comprises a first space portion 411accommodating the other end of the screw 20 and a second space portion 412 accommodating the other end of the cylinder 30 and part of the screw 20, a cover 23 which closes the open side of the main body 41 and in which a grain outlet 42 is formed, and a clamp 43 which attaches the cover 23 to the main body 41.
Patent NZ-586165-A (NZ)
Title: A method for vapour or electro-depositing an alloy control material on a metal substrate
Inventor: LIU QIYANG
IPC: C25D3/00
Filed: 2008-12-09
Abstract: A method for coating a metal substrate with a coating material comprising an alloy of aluminium and zinc is disclosed, wherein the method comprises the steps of:(a) vapour or electro-depositing an alloy control material selected from the group comprising anyone or more of silicon (Si), titanium (Ti), manganese (Mn), niobium (Nb), tantalum (Ta) and tungsten (W) onto the substrate; and(b) passing the substrate through a bath of molten coating material comprising aluminium and zinc and forming a coating of the coating material onto the deposited alloy control material; wherein the method may further comprise: (c) adding the alloy control material to the bath of molten coating material to minimise dissolution of the vapour or electrodeposited alloy control material from the substrate as the substrate passes through the bath of molten coating material.
Patent NZ-586870-A (NZ)
Title: Controlled release formulations of levodopa, carbidopa andd a caboxylic acid
Inventor: HSU ANN
IPC: C07C229/00
Filed: 2008-12-26
Abstract: Disclosed is a multiparticulate, controlled release oral solid formulation of levodopa comprising: a. a controlled release component comprising a core of levodopa and carbidopa which is coated with one or more enteric polymers; b. a carboxylic acid component which is coated with one or more enteric polymers; and c. an immediate release component comprising a mixture of levodopa and carbidopa, wherein the controlled release component, the immediate release component and the carboxylic acid component are distinct, separable beads or granules; and wherein the carboxylic acid component (b) comprises a carboxylic acid that is not in (a) and (c).
Patent NZ-586966-A (NZ)
Title: Method for operating a heat pump in low air temperatures by modulating refrigerant and air movements
Inventor: PUSSELL PATRICK
IPC: F28F13/00
Filed: 2008-12-19
Abstract: Disclosed is a method for operating a heat pump (100) in low ambient air temperatures. The method comprises periodically or temporarily halting flow of refrigerant through an evaporator (170) of the heat pump and providing forced airflow across the evaporator using a fan (160) while the refrigerant flow is halted. The method enables operation of the heat pump at low ambient temperatures and provides a means for de-icing the evaporator when operating at low ambient temperatures. The method is particularly applicable to heat pumps having an evaporator located outdoors, such as domestic and industrial water heating systems.
Patent NZ-591945-A (NZ)
Title: Disubstituted phthalazine hedgehog pathway antagonists
Inventor: BASTIAN JOLIE ANNE
IPC: A61K31/502
Filed: 2009-10-22
Abstract: Disclosed is a compound of formula (I) where the substituents are as disclosed in the description wherein, R1 is hydrogen, fluoro, cyano, trifluoromethyl or methoxy; R2 is hydrogen, fluoro or trimethylfluoro; R3 is hydrogen or chloro, provided that at least one of R2 and R3 is hydrogen; R4 is chloro, fluoro, cyano, trifluoromethyl, difluoromethoxy, methoxy or trifluoromethoxy; and the N-N heterocycle represents a substituted piperazine-1,4-diyl. Examples of the compounds of formula (I) are: N-(4-Fluorophenyl)-4-(4-(4-fluorophenyl)phthalazin-1-yl)-trans-2,5-dimethylpiperazine-1-carboxamide hydrochloride; N-(4-Fluorophenyl)-4-(4-(4-fluorophenyl)phthalazin-1-yl)-2-(hydroxymethyl)piperazine-1- carboxamide hydrochloride; and N-(4-Cyanophenyl)-2-methyl-4-(4-phenylphthalazin-1- yl)piperazine-1-carboxamide hydrochloride. The compounds are suitable for use in treating cancer such as brain cancer, basal cell carcinoma, esophagus cancer, gastric cancer, pancreatic cancer, biliary tract cancer, prostate cancer, breast cancer, small-cell lung cancer, non-small cell lung cancer, B-cell lymphoma, multiple myeloma, ovarian cancer, colorectal cancer, liver cancer, kidney cancer and melanoma. Also disclosed is a pharmaceutical compositions comprising compounds of formula (I).
Patent NZ-593169-A (NZ)
Title: Anticancer compounds
Inventor: COELLO MOLINERO LAURA
IPC: A61K38/08
Filed: 2009-12-18
Abstract: 593169 Disclosed are compounds of formula (I) where the substituents are as disclosed in the description and the compounds are useful in the treatment of cancer. In particular the compounds are cyclic depsipeptides Pipecolidepsin A, B or C.
Patent NZ-594230-A (NZ)
Title: Inhibitors of beta-secretase
Inventor: DILLARD LAWRENCE W
IPC: A61K31/4184
Filed: 2010-03-12
Abstract: 594230 Disclosed are spiro condensed benzofuranyl, indanyl or tetrahydronaphthalene compounds of formula I containing two spiro centres with variable X either -O-, -C(RaRb)-C(R3R4)-, -C(R3R4)-C(RaRb)- or -C(R3R4)-; Z is -C(=O)-, -C(=S)-, -C(=NR15)-, -O-, -C(=O)C(R16R17)-, - C(R16R17)C(=O)-, -C(=S)C(R16R17)-, C(R16R17) C(=S)-, -N(R18)-, -(CR16R17)m-, -O-(CR16R17)-, or -(CR16R17)- O--,; and R8 and R9 combine to form a 3-14 membered ring optionally containing 1-3 heteroatoms and the other variables are as defined, for example 3-(spiro[spiro[2,3-dihydro-indene-2,1'-(4-oxacyclohexane)]-1,5'-(3-amino-2-methyl-2H-[1,2,4]oxadiazole)]-6-yl)benzonitrile. Pharmaceutical compositions of the compounds are also disclosed and such compounds are intended for use as BACE inhibitors, for treatment of conditions such as Alzheimer's and glaucoma.
Patent NZ-594683-A (NZ)
Title: Coolant recovery and waste separation system
Inventor: FORLONG MURRAY HOULTON
IPC: B23C5/28
Filed: 2011-08-19
Abstract: 594683 Disclosed is a below plate coolant recovery and waste separation system for a combined machining and thermal cutting machine for cutting metal plate. The below plate coolant recovery and waste separation system includes a trolley structure being located underneath the table adapted to support a fume chamber and coolant tray. The trolley is constructed to be movable in the X axis, and be movable in response to the location of the cutting tools which move with the gantry along the rails to be positioned over the table and plate to be cut, during use in cutting the plate in combination such that the coolant or cutting fluid can be captured and reused and be kept separate from the dry waste or dross generated during the cutting process. The trolley structure is suspended under the cutting table and includes a chamber and tray for movably supporting at least one fume extraction chamber and at least one tray for receiving and removing coolant, whereby the coolant recovery and waste separation system is synchronised with the movement of the cutting tools by the control system on the machine. Also included is a machine having coolant recovery and waste separation that combines a machining head with coolant and thermal cutting for cutting metal plates.
Patent NZ-597645-A (NZ)
Title: Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders
Inventor: CHANG TSE-WEN
IPC: A61K9/00
Filed: 2010-06-30
Abstract: 597645 The present disclosure discloses topical pharmaceutical formulations of berberine and its biologically equivalent analogues, such as jatrorrhizine, palmatine, coptisine, 9-demethylberberine, 9-demethylpalmatine, 13-hydroyberberine, berberrubine, palmatrubine, 9-O-ethylberberrubine, 9-O-ethyl-13-ethylberberrubine, 13-methyldihydroberberine N-methyl salt, tetrahydroprotoberberines and N-methyl salts thereof, and 9-lauroylberberrubine chloride, for the treatment of rosacea and other red face-related skin disorders. The topical pharmaceutical formulations of this invention contain purified berberine as the primary active drug ingredient at concentrations higher than 0.02%. The invention also discloses methods of treating rosacea and other red face related skin disorders, such as rosacea, acne vulgaris, seborrheic dermatitis, photodermatitis, contact dermatitis, steroid-induced rosacea-like dermatitis, and EGFR inhibitors-induced acneiform dermatitis, comprising the administration of topical pharmaceutical formulations according to the present disclosure.
Patent NZ-600147-A (NZ)
Title: Utility meter with temperature based actuation of a remote disconnect switch
Inventor: LAFRANCE RYAN MARC
IPC: G01F15/00
Filed: 2012-05-22
Abstract: Disclosed is a utility meter (100) with a disconnect switch (200) that is operable in response to a detected temperature condition. The meter (100) is comprised of a processor (120), a remote disconnect switch (200), a temperature sensor (210) and a temperature monitoring circuit (225). The processor (120), the remote disconnect switch (200) and the temperature sensor (210) are in communication via the temperature monitoring circuit (225). The temperature monitoring circuit (225) is operable to receive a temperature of the utility meter (100) from the temperature sensor (210) and provide a signal (270) to the remote disconnect switch (200) when the temperature sensor (210) senses a temperature that exceeds a predetermined temperature range.
Patent NZ-600156-A (NZ)
Title: Degradable removable implant for the sustained release of an active compound
Inventor: KRAUS GUENTER
IPC: C07D239/48
Filed: 2010-12-20
Abstract: Disclosed is a degradable, removable, pharmaceutical subcutaneous implant for the sustained release of one or more active agents in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain the one or more active agents (such as rilpivirine), wherein the microparticles are fabricated from a biocompatible, biodegradable polymer (such as copolymers of lactide and glycolide), wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings, and wherein the degradation rate of the polymer that composes the tube is slower than the rate of degradation of the microparticles.
Patent NZ-602567-A (NZ)
Title: Seating arrangement, seat unit, tray table and seating system
Inventor: VICTORIA ANNE BAMFORD
IPC: B60N2/02
Filed: 2011-07-20
Abstract: 602567 Passenger vehicle seating arrangements consist of seats in a row that have leg rests that are contiguous to one another and when deployed form with the seat pan a reconfigurable horizontal surface to support at least two passengers in a direction parallel to the row. Various embodiments are disclosed.
Patent NZ-603169-A (NZ)
Title: Peptide conjugates of glp-1 receptor agonists and gastrin and their use
Inventor: OSTERLUND TORBEN
IPC: C07K19/00
Filed: 2011-04-27
Abstract: A peptide conjugate having the formula I: R1 – Z – L – Y – R2 wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl; Z is a peptide sequence having the formula IVa His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Z9-Leu-Ser-Z12-GI n-Met-Glu-Z 16-Glu-Ala-Val-Arg-Leu-PheIle- Glu-Trp-Leu-Z27-Z28 (IVa) wherein Z9 is selected from Glu and Asp; Z12 is selected from Lys and Orn; Z16 is selected from Glu and Lys; Z27 is selected from Lys and Orn; Z28 is selected from Asn and Asp or is absent; L is a peptide sequence having the formula IVb L 1-L2-L3-L4 (IVb) wherein L 1 is selected from Peg3, Gin, Cys, Lys and Orn or is absent; L2 is selected from Peg3, Gin, Cys, Lys and Orn or is absent; L3 is selected from Peg3, Gin, Cys, Lys and Orn or is absent; L4 is selected from Peg3, Gin, Cys, Lys and Orn or is absent; Y is a peptide sequence having the formula IVc Y12-Y13-Trp-Leu-Asp-Phe (IVc) wherein Y12 is Tyr or is absent; and Y13 is Gly or is absent; or a pharmaceutically acceptable salt or solvate thereof.
Patent NZ-604513-A (NZ)
Title: Process and equipment for the fabrication of glass containers with internally threaded neck
Inventor: VILLARET DE CHAUVIGNY BENOÎT
IPC: C03B9/325
Filed: 2011-05-30
Abstract: The present invention relates to a process and equipment for the fabrication of glass containers with internally threaded neck and such containers. The plunger (6) is from the glass leaving an imprint corresponding to the mouth (M) of a bottle, wherein the plunger has at least one helical groove (15) in its outside surface. During the extraction, the plunger is rotated around a longitudinal axis (X-X) performing a roto-translational motion to unscrew the plunger out of the partially solidified glass, leaving an internal thread in the mouth (M) of the bottle. The roto-translational motion for the extraction of the plunger is generated by: a linear actuator (30) acting on the plunger (6), thereby effecting a linear movement of the plunger (6) along said longitudinal axis (X-X), a guide body (14) wherein the plunger (6) is moved relative to the guide body (14) along said longitudinal axis (X-X), and a helical guide (16, 17) coaxial to the longitudinal axis (X-X) and being provided between said guide body (14) and said plunger (6) and transforming said linear movement effected by said linear actuator (30) on said plunger (6) into said roto-translational motion of said plunger (6).
Patent NZ-607475-A (NZ)
Title: Apparatus and method for cutting out a vehicle glazing panel
Inventor: DAVIES CHRISTOPHER
IPC: B60J1/02
Filed: 2011-11-08
Abstract: A winder unit (1) for use with a cutting wire in cutting out a vehicle glazing panel is disclosed. The winder unit (1) comprises first (3) and second (4) winder spools for winding cutting wire. The winder unit (1) also comprises a suction mount (2) for mounting the winder unit (1). The suction mount (2) includes a single suction device (8). The winder unit (1) further comprises at least one rotatable guide element in the form of a pulley wheel (5, 6) and is adjustable in position or orientation with respect to the winder spools (3, 4) and/or suction mount (2).
Patent NZ-610463-A (NZ)
Title: Systems and methods to coordinate transmissions in distributed wireless systems via user clustering
Inventor: FORENZA ANTONIO
IPC: H04L1/02
Filed: 2011-10-31
Abstract: Disclosed is a multiuser (MU) multiple antenna system (MU-MAS). The system comprises one or more centralised units communicatively coupled to multiple distributed transceiver stations or antennas via a network the network consisting of wireline or wireless links or a combination of both which employed as a backhaul communication channel. The centralised unit transforming the N data streams into M precoded data streams. Each precoded data stream is a combination of some or all N data streams. The M precoded data streams are sent over the network to the distributed transceiver stations. The distributed transceiver stations simultaneously sends the precoded data streams over wireless links to at least one client device such that at least one client device receives at least one of the original N data streams.
Patent NZ-611428-A (NZ)
Title: Novel modulators and methods of use
Inventor: HAMPL JOHANNES
IPC: G01N33/574
Filed: 2011-12-07
Abstract: Disclosed is an antibody comprising a chimeric, CDR-grafted, humanised, or a recombinant human antibody, or fragment thereof, that specifically binds to human EFNA4 and that competes for binding to human EFNA4 with an antibody comprising the heavy and light chains of the sequences as defined in the specification.
Patent NZ-703403-A (NZ)
Title: Prognosis prediction for colorectal cancer
Inventor: REEVE ANTHONY E
IPC: G01N33/68
Filed: 2005-12-22
Abstract: A method for determining the prognosis of a cancer, comprises (a) providing a sample of the cancer; (b) detecting the expression level of a CRCPM family member in the sample; and (c) determining the prognosis of the cancer
Patent NZ-712526-A (NZ)
Title: Method for processing vanadium-titanium magnetite finished ores by using wet process
Inventor: QI TAO
IPC: C22B34/22
Filed: 2014-04-10
Abstract: A method for processing vanadium-titanium magnetite finished ores by using a wet process. The method comprises the steps: extracting vanadium from vanadium-titanium magnetite finished ores and processing, by using the vanadium extraction method, obtained leaching residue by using a wet process, so as to obtain titanium; and calcining the remaining liquid extracted during the vanadium extraction, so as to prepare ferric oxide. The flow of the method is short, and the energy consumption is low, thereby avoiding waste of a titanium resource.
Patent NZ-714202-A (NZ)
Title: Probiotics and methods of use
Inventor: FASANO FRANCESCA
IPC: A61K35/74
Filed: 2014-05-09
Abstract: The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.